Molly Silkowski, DO (@mollysilkowski) 's Twitter Profile
Molly Silkowski, DO

@mollysilkowski

•Advanced Heart Failure/Transplant Fellow @MUSC •Upcoming Interventional Cardiology fellow. •Interested in all things Shock and dogs.

ID: 1168495987419156481

calendar_today02-09-2019 12:09:03

169 Tweet

520 Takipçi

443 Takip Edilen

Anezi Uzendu, MD (@druzendu) 's Twitter Profile Photo

In 2016, I watched my first coronary angiogram. Quinn Capers, IV took me to the cath lab after my The Ohio State University College of Medicine interview. 7 years and innumerable guidance and mentorship sessions later I'm joining him as interventional cardiology faculty at UTSW Media Relations Representation matters!

Molly Silkowski, DO (@mollysilkowski) 's Twitter Profile Photo

SO honored and thrilled to continue my training at MUSC! To be the best, you have to surround yourself with the best. Cheers to spending a year with faculty that are incredibly talented and create the most comfortable learning environment. #wedgesat4all

Cardiac Interventions Today (@cardiacinterv) 's Twitter Profile Photo

Molly Silkowski, DO (Molly Silkowski, DO), and Anbukarasi Maran, MD (Arasi Maran), provide an up-to-date assessment of coronary perforation, including a look at balloon tamponade, thrombin, and multiple technological management tools. citoday.com/articles/2024-…

Anthony Carnicelli, MD FACC (@carnicelli_ant) 's Twitter Profile Photo

🔥🚒 Pioneering the role of full-time, dedicated “temporary MCS coordinator” at MUSC Cardiology - VERY proud to be a part of this group!! ahajournals.org/doi/abs/10.116…

Molly Silkowski, DO (@mollysilkowski) 's Twitter Profile Photo

Had the best time meeting the leading figures in the world of cardiogenic shock and learning more about mechanics and the future of RV/LV unloading. Til next time ACURE!

Cardiac Interventions Today (@cardiacinterv) 's Twitter Profile Photo

Drs. Harshith Chandrakumar (Harshith Chandrakumar), Molly Silkowski (Molly Silkowski, DO), & Anbukarasi Maran (Arasi Maran), discuss calcific coronary lesion imaging & treatment, diving into the pros & cons of available imaging modalities & modification therapies. citoday.com/articles/2024-…

BiykemBozkurt (@biykemb) 's Twitter Profile Photo

Sacubitril/Valsartan in patients with HF & deterioration in eGFR to <30 with therapy. Continuation of ARNi was associated with persistent clinical benefit and no incremental risk. JACC Journals #JACCHF jacc.org/doi/10.1016/j.…

Sacubitril/Valsartan in patients with HF &amp; deterioration in eGFR to &lt;30 with therapy. Continuation of ARNi was associated with persistent clinical benefit and no incremental risk. <a href="/JACCJournals/">JACC Journals</a> #JACCHF jacc.org/doi/10.1016/j.…
JHLT (@thejhlt) 's Twitter Profile Photo

Efficacy and safety were consistent across baseline cardiac index subgroups in PULSAR and STELLAR clinical trials, supporting use of sotatercept in PAH patients irrespective of baseline cardiac hemodynamics. 🔗: jhltonline.org/article/S1053-…